Abstract
HK Reddel, WW Busse, S Pedersen. Lancet. 2017;389(10065):157–166 The 3-year Steroid Treatment as Regular Therapy (START) study evaluated the symptom-based cutoff of >2 days per week for starting daily inhaled steroid therapy for management of mild asthma. Participants ( N = 7138, ages 4–66 years) were from 32 countries, had mild asthma diagnosed within the past 2 years, and no previous regular corticosteroid therapy. This post-hoc analysis of a randomized control trial comparing once-daily inhaled …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
